Literature DB >> 25183731

Rat indwelling urinary catheter model of Candida albicans biofilm infection.

Jeniel E Nett1, Erin G Brooks2, Jonathan Cabezas-Olcoz3, Hiram Sanchez3, Robert Zarnowski3, Karen Marchillo1, David R Andes4.   

Abstract

Indwelling urinary catheters are commonly used in the management of hospitalized patients. Candida can adhere to the device surface and propagate as a biofilm. These Candida biofilm communities differ from free-floating Candida, exhibiting high tolerance to antifungal therapy. The significance of catheter-associated candiduria is often unclear, and treatment may be problematic considering the biofilm drug-resistant phenotype. Here we describe a rodent model for the study of urinary catheter-associated Candida albicans biofilm infection that mimics this common process in patients. In the setting of a functioning, indwelling urinary catheter in a rat, Candida proliferated as a biofilm on the device surface. Characteristic biofilm architecture was observed, including adherent, filamentous cells embedded in an extracellular matrix. Similar to what occurs in human patients, animals with this infection developed candiduria and pyuria. Infection progressed to cystitis, and a biofilmlike covering was observed over the bladder surface. Furthermore, large numbers of C. albicans cells were dispersed into the urine from either the catheter or bladder wall biofilm over the infection period. We successfully utilized the model to test the efficacy of antifungals, analyze transcriptional patterns, and examine the phenotype of a genetic mutant. The model should be useful for future investigations involving the pathogenesis, diagnosis, therapy, prevention, and drug resistance of Candida biofilms in the urinary tract.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25183731      PMCID: PMC4249295          DOI: 10.1128/IAI.02284-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Biofilm formation: a clinically relevant microbiological process.

Authors:  R M Donlan
Journal:  Clin Infect Dis       Date:  2001-09-20       Impact factor: 9.079

3.  A contact-activated kinase signals Candida albicans invasive growth and biofilm development.

Authors:  Carol A Kumamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-30       Impact factor: 11.205

4.  A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.

Authors:  Prasanna D Khot; Peter A Suci; R Lance Miller; Raoul D Nelson; Bonnie J Tyler
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

5.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

6.  Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model.

Authors:  D Andes; M van Ogtrop
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

7.  Candida albicans biofilm formation in a new in vivo rat model.

Authors:  Markéta Řičicová; Soňa Kucharíková; Hélène Tournu; Jelle Hendrix; Helena Bujdáková; Johan Van Eldere; Katrien Lagrou; Patrick Van Dijck
Journal:  Microbiology       Date:  2009-12-03       Impact factor: 2.777

8.  Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Diagnosis and inflammatory response of patients with candiduria.

Authors:  S Helbig; J M Achkar; N Jain; X Wang; P Gialanella; M Levi; B C Fries
Journal:  Mycoses       Date:  2012-05-10       Impact factor: 4.377

10.  Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis.

Authors:  Ying-Lien Chen; Alexandra Brand; Emma L Morrison; Fitz Gerald S Silao; Ursela G Bigol; Fedelino F Malbas; Jeniel E Nett; David R Andes; Norma V Solis; Scott G Filler; Anna Averette; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2011-04-29
View more
  17 in total

Review 1.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

Review 2.  Plasticity of Candida albicans Biofilms.

Authors:  David R Soll; Karla J Daniels
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-01       Impact factor: 11.056

3.  Assessment and Optimizations of Candida albicans In Vitro Biofilm Assays.

Authors:  Matthew B Lohse; Megha Gulati; Ashley Valle Arevalo; Adam Fishburn; Alexander D Johnson; Clarissa J Nobile
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  Host contributions to construction of three device-associated Candida albicans biofilms.

Authors:  Jeniel E Nett; Robert Zarnowski; Jonathan Cabezas-Olcoz; Erin G Brooks; Jörg Bernhardt; Karen Marchillo; Deane F Mosher; David R Andes
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

5.  Visualization of Biofilm Formation in Candida albicans Using an Automated Microfluidic Device.

Authors:  Megha Gulati; Craig L Ennis; Diana L Rodriguez; Clarissa J Nobile
Journal:  J Vis Exp       Date:  2017-12-14       Impact factor: 1.355

Review 6.  Development and regulation of single- and multi-species Candida albicans biofilms.

Authors:  Matthew B Lohse; Megha Gulati; Alexander D Johnson; Clarissa J Nobile
Journal:  Nat Rev Microbiol       Date:  2017-10-03       Impact factor: 60.633

7.  Management of candiduria in hospitalized patients: a single-center study on the implementation of IDSA guidelines and factors affecting clinical decisions.

Authors:  Zhengxin He; Xiaosai Huo; Daxin Lei; Huihai Zhao; Keran Jia; Fukun Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-07-30       Impact factor: 3.267

Review 8.  Candida albicans biofilms: development, regulation, and molecular mechanisms.

Authors:  Megha Gulati; Clarissa J Nobile
Journal:  Microbes Infect       Date:  2016-01-22       Impact factor: 2.700

Review 9.  The Host's Reply to Candida Biofilm.

Authors:  Jeniel E Nett
Journal:  Pathogens       Date:  2016-03-18

Review 10.  Candida Species Biofilms' Antifungal Resistance.

Authors:  Sónia Silva; Célia F Rodrigues; Daniela Araújo; Maria Elisa Rodrigues; Mariana Henriques
Journal:  J Fungi (Basel)       Date:  2017-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.